FDA Approved: METRONIDAZOLE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

The FDA approved a supplemental application for metronidazole filed by Taro Pharmaceuticals U.S.A., Inc. (ANDA077819).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amebiasis
• Bacterial Vaginosis
• Giardiasis
• Intra-abdominal Infection
• Pelvic Inflammatory Disease
• Trichomoniasis

Drugs mentioned

• METRONIDAZOLE (Metronidazole)

Snippet

SUPPL AP for METRONIDAZOLE (METRONIDAZOLE)